Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1998-12-31
|
pubmed:abstractText |
Patients with ESRD have excessive cardiovascular morbidity and mortality. In postmenopausal women with normal renal function, estrogen replacement therapy decreases cardiovascular mortality by 50%, in part because of their beneficial effects on the lipoprotein profile. Because of similarities in the lipoprotein profile between healthy, postmenopausal women, and women with ESRD, we examined the effects of estrogen replacement on lipoproteins in 11 postmenopausal women with ESRD.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0085-2538
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
54
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1344-50
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:9767554-Cardiovascular Diseases,
pubmed-meshheading:9767554-Cholesterol, HDL,
pubmed-meshheading:9767554-Cross-Over Studies,
pubmed-meshheading:9767554-Estradiol,
pubmed-meshheading:9767554-Estrogen Replacement Therapy,
pubmed-meshheading:9767554-Female,
pubmed-meshheading:9767554-Humans,
pubmed-meshheading:9767554-Kidney Failure, Chronic,
pubmed-meshheading:9767554-Lipoproteins,
pubmed-meshheading:9767554-Menopause,
pubmed-meshheading:9767554-Middle Aged,
pubmed-meshheading:9767554-Renal Dialysis,
pubmed-meshheading:9767554-Risk Factors
|
pubmed:year |
1998
|
pubmed:articleTitle |
Effects of estrogen replacement therapy on the lipoprotein profile in postmenopausal women with ESRD.
|
pubmed:affiliation |
Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|